Envestnet Portfolio Solutions, Inc. Adma Biologics, Inc. Call Options Transaction History
Envestnet Portfolio Solutions, Inc.
- $23.7 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ADMA
# of Institutions
349Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$399 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$389 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$318 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$242 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$118 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.2B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...